ホーム / コンテンツ / ホワイトペーパー / Leveraging Biosimulation to Inform Optimal Use of COVID-19 Vaccines

Leveraging Biosimulation to Inform Optimal Use of COVID-19 Vaccines

2021年2月3日 White Paper

By: Piet van der Graaf

お問合せ

By: Dr. Piet van der Graaf, SVP

筆者について

By: Piet van der Graaf

関連コンテンツ

Why Medical Writing Services Use Style Guides & Lexicons

eChalk Talk: Avoid getting “lost in translation” – Increase confidence in translational research using biosimulation

録画ウェビナー

PBPK Modeling to Support Bioequivalence & Generic Product Approvals

Drug repurposing: Misconceptions, challenges, and opportunities for academic researchers

Powered by Translations.com GlobalLink OneLink Software